Ann Versporten

6.5k total citations · 1 hit paper
84 papers, 3.1k citations indexed

About

Ann Versporten is a scholar working on Applied Microbiology and Biotechnology, Epidemiology and General Health Professions. According to data from OpenAlex, Ann Versporten has authored 84 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Applied Microbiology and Biotechnology, 37 papers in Epidemiology and 20 papers in General Health Professions. Recurrent topics in Ann Versporten's work include Antibiotic Use and Resistance (60 papers), Pneumonia and Respiratory Infections (27 papers) and Antibiotic Resistance in Bacteria (16 papers). Ann Versporten is often cited by papers focused on Antibiotic Use and Resistance (60 papers), Pneumonia and Respiratory Infections (27 papers) and Antibiotic Resistance in Bacteria (16 papers). Ann Versporten collaborates with scholars based in Belgium, United Kingdom and Uganda. Ann Versporten's co-authors include Herman Goossens, Samuel Coenen, Mike Sharland, Vanessa Vankerckhoven, Y. Glupczynski, Alexander M. Hirschl, Manfred Kist, M López-Brea, Françis Mégraud and Nico Drapier and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Ann Versporten

78 papers receiving 3.1k citations

Hit Papers

Helicobacter pylori resistance to antibiotics in Europe a... 2012 2026 2016 2021 2012 200 400 600

Peers

Ann Versporten
Jeroen Schouten Netherlands
C. Suetens Belgium
Douglas N. Fish United States
Priya A. Prasad United States
R.A. Seaton United Kingdom
Benedikt Huttner Switzerland
Robert C. Owens United States
Jeroen Schouten Netherlands
Ann Versporten
Citations per year, relative to Ann Versporten Ann Versporten (= 1×) peers Jeroen Schouten

Countries citing papers authored by Ann Versporten

Since Specialization
Citations

This map shows the geographic impact of Ann Versporten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Versporten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Versporten more than expected).

Fields of papers citing papers by Ann Versporten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Versporten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Versporten. The network helps show where Ann Versporten may publish in the future.

Co-authorship network of co-authors of Ann Versporten

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Versporten. A scholar is included among the top collaborators of Ann Versporten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Versporten. Ann Versporten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Masaisa, Florence, Ines Pauwels, Ann Versporten, et al.. (2024). Prescription Practices and Usage of Antimicrobials in a Tertiary Teaching Hospital in Rwanda: A Call for Antimicrobial Stewardship. Antibiotics. 13(11). 1032–1032. 1 indexed citations
3.
Versporten, Ann, et al.. (2023). AWaRe classification of Antibiotics prescribed within 2018-2021 for hospitalised medical and surgical patients in Uyo, Nigeria. Pan African Medical Journal. 46. 80–80. 2 indexed citations
4.
Roberts, Alero Ann, Iretiola Fajolu, Oluwakemi Ololade Odukoya, et al.. (2021). Roll out of a successful antimicrobial stewardship programme in Lagos University Teaching Hospital Nigeria using the Global-Point Prevalence Survey. African Journal of Clinical and Experimental Microbiology. 22(2). 260–272. 7 indexed citations
5.
Nwajiobi-Princewill, P.I., Nubwa Medugu, Ann Versporten, et al.. (2021). Using longitudinal antibiotic point prevalence survey (PPS) to drive antimicrobial stewardship programmes in a Nigerian tertiary hospital. African Journal of Clinical and Experimental Microbiology. 22(2). 284–289. 3 indexed citations
6.
Umeokonkwo, Chukwuma David, Oyinlola O. Oduyebo, Ann Versporten, et al.. (2021). Point prevalence survey of antimicrobial consumption and resistance: 2015-2018 longitudinal survey results from Nigeria. African Journal of Clinical and Experimental Microbiology. 22(2). 252–259. 5 indexed citations
7.
Oyetibo, Ganiyu Oladunjoye, et al.. (2021). Empirical antibiotherapy as a potential driver of antibiotic resistance: observations from a point prevalence survey of antibiotic consumption and resistance in Gombe, Nigeria. African Journal of Clinical and Experimental Microbiology. 22(2). 273–278. 3 indexed citations
8.
Saleem, Zikria, Mohamed Azmi Hassali, Brian Godman, et al.. (2020). Point prevalence surveys of antimicrobial use: a systematic review and the implications. Expert Review of Anti-infective Therapy. 18(9). 897–910. 58 indexed citations
9.
Frenette, Charles, Greg J. German, Kevin Afra, et al.. (2020). The 2017 global point prevalence survey of antimicrobial consumption and resistance in Canadian hospitals. Antimicrobial Resistance and Infection Control. 9(1). 104–104. 21 indexed citations
10.
Zanichelli, Veronica, Annelie A Monnier, Inge C. Gyssens, et al.. (2018). Variation in antibiotic use among and within different settings: a systematic review. Journal of Antimicrobial Chemotherapy. 73(suppl_6). vi17–vi29. 44 indexed citations
11.
Scott, Michael, C. Hibberd, Ann Versporten, et al.. (2018). Longitudinal point prevalence survey of antibacterial use in Northern Ireland using the European Surveillance of Antimicrobial Consumption (ESAC) PPS and Global-PPS tool. Epidemiology and Infection. 146(8). 985–990. 19 indexed citations
12.
Elhajji, Feras Darwish, Abdel Qader Al Bawab, Michael Scott, et al.. (2018). Comparative point prevalence survey of antimicrobial consumption between a hospital in Northern Ireland and a hospital in Jordan. BMC Health Services Research. 18(1). 849–849. 30 indexed citations
13.
14.
Gharbi, Myriam, Katja Doerholt, Stefania Vergnano, et al.. (2016). Using a simple point-prevalence survey to define appropriate antibiotic prescribing in hospitalised children across the UK. BMJ Open. 6(11). e012675–e012675. 55 indexed citations
15.
Luca, Maia De, Daniele Donà, Carlotta Montagnani, et al.. (2016). Antibiotic Prescriptions and Prophylaxis in Italian Children. Is It Time to Change? Data from the ARPEC Project. PLoS ONE. 11(5). e0154662–e0154662. 56 indexed citations
17.
Spyridis, Νikos, Garyfallia Syridou, Herman Goossens, et al.. (2015). Variation in paediatric hospital antibiotic guidelines in Europe. Archives of Disease in Childhood. 101(1). 72–76. 30 indexed citations
18.
Versporten, Ann, et al.. (2013). The Antibiotic Resistance and Prescribing in European Children Project. The Pediatric Infectious Disease Journal. 32(6). e242–e253. 115 indexed citations
19.
Mégraud, Françis, Samuel Coenen, Ann Versporten, et al.. (2012). Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut. 62(1). 34–42. 648 indexed citations breakdown →
20.
Versporten, Ann, Samuel Coenen, Niels Adriaenssens, et al.. (2011). European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe (1997-2009). Journal of Antimicrobial Chemotherapy. 66(suppl 6). vi13–vi23. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026